Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.19 USD | +0.46% | +1.86% | -34.23% |
Mar. 20 | HC Wainwright Adjusts Coherus BioSciences' Price Target to $11 From $13, Keeps Buy Rating | MT |
Mar. 14 | Coherus BioSciences Shares Fall After Workforce Reduction Plan; Q4 Loss | MT |
Financials (USD)
Sales 2024 * | 262M | Sales 2025 * | 357M | Capitalization | 247M |
---|---|---|---|---|---|
Net income 2024 * | -69M | Net income 2025 * | -20M | EV / Sales 2024 * | 1.97 x |
Net Debt 2024 * | 268M | Net Debt 2025 * | 286M | EV / Sales 2025 * | 1.49 x |
P/E ratio 2024 * |
-3.97
x | P/E ratio 2025 * |
-20.2
x | Employees | 306 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.92% |
Latest transcript on Coherus BioSciences, Inc.
1 day | +0.46% | ||
1 week | +1.86% | ||
Current month | -8.37% | ||
1 month | -6.01% | ||
3 months | -8.75% | ||
6 months | -31.24% | ||
Current year | -34.23% |
Managers | Title | Age | Since |
---|---|---|---|
Denny Lanfear
CEO | Chief Executive Officer | 68 | 10-08-31 |
Bryan Mcmichael
DFI | Director of Finance/CFO | 46 | 21-02-28 |
Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Stolper
BRD | Director/Board Member | 52 | 21-01-04 |
Mats Wahlström
BRD | Director/Board Member | 70 | 11-12-31 |
Ali Satvat
BRD | Director/Board Member | 46 | 14-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 2.18 | 0.00% | 811,796 |
24-04-22 | 2.18 | +5.31% | 1,499,626 |
24-04-19 | 2.07 | +3.50% | 2,879,861 |
24-04-18 | 2 | -6.98% | 1,918,188 |
24-04-17 | 2.15 | 0.00% | 1,257,356 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.23% | 247M | |
-0.49% | 105B | |
+3.31% | 97.5B | |
+2.88% | 22.19B | |
-16.16% | 21.33B | |
-7.42% | 18.68B | |
-41.41% | 16.6B | |
-22.87% | 14.52B | |
+6.32% | 14.09B | |
+21.46% | 10.99B |
- Stock Market
- Equities
- CHRS Stock